Magnesium sulfate is widely prescribed postpartum for seizure prophylaxis in women with preeclampsia and other hypertensive disorders of pregnancy, yet its potential effects on lactation outcomes remain underexplored.
Objectives:
To evaluate and synthesize the current evidence on how postpartum magnesium sulfate therapy affects lactation outcomes, including breastfeeding initiation, exclusivity, duration, pumping habits, and secretory activation (SA).
Methods:
This integrative review followed PRISMA guidelines and Whittemore and Knafl’s framework. Literature was obtained from five databases without date restrictions. A total of 11 studies met the inclusion criteria. Methodological quality was evaluated using the Joanna Briggs Institute tools and Melnyk and Fineout-Overholt’s hierarchy of evidence.
Results:
Data were synthesized from 11 studies published between 1993 and 2023, encompassing 2,842 participants across diverse hospital settings. Findings indicate that extended postpartum magnesium sulfate administration is associated with delayed breastfeeding initiation, delayed maternal perception of SA, and greater reliance on milk expression. Most researchers did not report maternal side effects or quantitatively measure the frequency of breastfeeding or pumping. Studies reported hospital policies that restricted rooming-in and breastfeeding during magnesium infusion.
Conclusions:
Postpartum magnesium sulfate administration is associated with delays in lactation initiation, missing the evidence-based critical window for frequent early milk removal. However, studies in this review rarely examine maternal side effects or feeding frequency in detail. Future research should use standardized definitions, document both frequency and mode of milk removal, evaluate objective measures of SA, evaluate maternal experience, and hospital policies.
TangY, ZhangY, LiW, et al.Global burden of hypertensive disorders of pregnancy from 1990 to 2021: An analysis of the Global Burden of Disease Study 2021. BMJ Open, 2025; 15(2):e079248.
American College of Obstetricians and Gynecologists. Gestational hypertension and preeclampsia. Practice Bulletin Number 222. Obstet Gynecol, 2020; 135(6):e237–e260.
5.
CreangaAA, SyversonC, SeedK, et al.Pregnancy-related mortality in the United States, 2011–2013. Obstet Gynecol, 2017; 130(2):366–373.
6.
SchwartzKS, StanhewiczAE. Maternal microvascular dysfunction during and after preeclamptic pregnancy. Compr Physiol, 2024; 14(4):5703–5727.
7.
WuP, HaththotuwaR, KwokCS, et al.Preeclampsia and future cardiovascular health: A systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes, 2017; 10(2):e003497.
8.
ChiarelloDI, AbadC, RojasD, et al.Oxidative stress: Normal pregnancy versus preeclampsia. Biochim Biophys Acta Mol Basis Dis, 2018; 1864(5 Pt B):1875–1881.
9.
American Family Physician. Magnesium sulfate before anticipated preterm birth for neuroprotection. Am Fam Physician, 2019; 99(11):690–691.
KarrarSA, AlhozaliH, MohammedsalehZ, et al.Hypertensive disorders of pregnancy. In: StatPearls. StatPearls Publishing: Treasure Island, FL; 2024.
12.
AltmanD, CarroliG, DuleyL, et al.Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet, 2002; 359(9321):1877–1890.
13.
PascoalAN, KatzL, PintoMH, et al.Serum magnesium levels during magnesium sulfate infusion at 1 gram/hour versus 2 grams/hour as a maintenance dose to prevent eclampsia in women with severe preeclampsia: A randomized clinical trial. Medicine (Baltimore), 2019; 98(32):e16779.
14.
SahaS, JahanN, DeyD, et al.Abbreviated 12-hour postpartum magnesium sulphate therapy is as effective as 24-hour therapy for seizure prophylaxis in severe preeclampsia and eclampsia. Cureus, 2025; 17(1):e76681.
15.
SpatzDL, Álvarez RodríguezS, BenjilanyS, et al.Having enough milk to sustain a lactation journey: A call to action. Nurs Womens Health, 2024; 28(4):256–263.
16.
FrohEB, SpatzDL, BogenDL. Re-framing secretory activation: A gap analysis of clinical-research interface. J Midwifery Womens Health, 2021; 66(1):26–34.
17.
JohnsonTJ, HobanR, JanesJE, et al.Early, frequent, unstructured milk expression: Key to establishing robust lactation for mothers of very preterm infants? J Perinatol, 2025; 45(1):105–114.
18.
NardellaD, CanavanM, SharifiM, et al.Quantifying the association between pump use and breastfeeding duration. J Pediatr, 2024; 274:114192.
19.
SpatzDL. Critical role of nighttime breast emptying. MCN Am J Matern Child Nurs, 2025; 50(2):116.
20.
AdamS, AuerbachLE, EngelaL, et al.Association between breastfeeding and subsequent hypertension in pregnancy. Am J Obstet Gynecol MFM, 2021; 3(5):100406.
21.
BonifacinoE, SchwartzEB, JunH, et al.Effect of lactation on maternal hypertension: A systematic review. Breastfeed Med, 2018; 13(9):578–588.
22.
TschidererL, SeekircherL, KunutsorSK, et al.Breastfeeding is associated with a reduced maternal cardiovascular risk: Systematic review and meta-analysis involving data from 8 studies and 1,192,700 parous women. J Am Heart Assoc, 2022; 11(2):e022746.
NardellaD, CanavanME, TaylorSN, et al.Hypertensive disorders of pregnancy and breastfeeding among US women. JAMA Netw Open, 2025; 8(7):e2521902.
25.
HorsleyA, LusambiliA, BwalyaK, et al.Association between exclusive breastfeeding and hypertensive disorders of pregnancy: A systematic review and meta-analysis. Arch Public Health, 2022; 80:208.
26.
LiJ, WangT, RenX. Breastfeeding outcomes and associated factors among women with hypertensive disorders of pregnancy: A systematic review. Midwifery, 2024; 139:104138.
27.
LiuX, LinJ. Hypertensive disorders of pregnancy and breastfeeding: A systematic review and meta-analysis. Int Breastfeed J, 2024; 19:32.
28.
BainES, MiddletonPF, CrowtherCA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: A systematic review. BMC Pregnancy Childbirth, 2013; 13:195.
29.
National Institute of Child Health and Human Development. Magnesium sulfate. In: Drugs and Lactation Database (LactMed). National Library of Medicine: Bethesda, MD; 2006. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501339/
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 2021; 372:n71.
32.
DenisonHJ, DoddsRM, NtaniG, et al.How to get started with a systematic review in epidemiology: An introductory guide for early career researchers. Arch Public Health, 2013; 71(1):21.
33.
MunnZ, BarkerT, MoolaS, et al.Methodological quality of case series studies: An introduction to the JBI critical appraisal tool. JBI Evid Synth, 2020; 18(10):2127–2133.
34.
MelnykBM, Fineout-OverholtE. Evidence-based practice in nursing & healthcare: a guide to best practice, 4th ed. Philadelphia: Wolters Kluwer; 2019.
35.
BurgessA, McDowellW, EbersoldS. Association between lactation and postpartum blood pressure in women with preeclampsia. MCN Am J Matern Child Nurs, 2019; 44(2):86–93.
36.
CorderoL, ValentineCJ, SamuelsP, et al.Breastfeeding in women with severe preeclampsia. Breastfeed Med, 2012; 7(6):457–463.
37.
CorderoL, StengerMR, LandonMB, et al.Comparison of breastfeeding initiation in mothers with preeclampsia with severe features and preeclampsia with diabetes. Am J Perinatol, 2020; 37(7):732–738.
38.
CorderoL, StengerMR, LandonMB, et al.Breastfeeding initiation in women with preeclampsia with severe features and preeclampsia without severe features: A comparison study. Breastfeed Med, 2021; 16(2):153–159.
39.
DemirciJ, SchmellaM, GlasserM, et al.Delayed lactogenesis II and potential utility of antenatal milk expression in women developing late-onset preeclampsia: A case series. BMC Pregnancy Childbirth, 2018; 18(1):68.
40.
Gutiérrez-VelaO, Nava-GuerreroEN, Caballero-FloresI, et al.Effectiveness of a shortened magnesium sulfate treatment for the prevention of eclampsia during the puerperium. Ginecol Obstet Mex, 2021; 89(11):865–874.
41.
HaldemanW. Delayed lactogenesis possibly related to magnesium sulfate use for pregnancy-induced hypertension. J Hum Lact, 1993; 9(3):178.
42.
MushtaqS, ZafarM, AhmedA, et al.Eight hours versus twenty four hours postpartum magnesium sulphate for prophylaxis in women with pre-eclampsia. Pak J Med Health Sci, 2023; 17(4):549–551.
43.
SitharaD, RajeswariKS, SivasundariM. Idiopathic thrombocytopenic purpura in pregnancy. J South Asian Fed Obstet Gynaecol, 2015; 7(2):95–96.
44.
Vigil-De GraciaP, RamirezR, DuránY, et al.Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: A randomized clinical trial. BMC Pregnancy Childbirth, 2017; 17(1):241.
45.
Vigil-DeGraciaP, LudmirJ, NgJ, et al.Is there benefit to continue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study. BJOG, 2018; 125(10):1304–1311.
46.
DiazV, LongQ, OladapoOT. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev, 2023; 10(10):CD007388.
47.
BurgessA, EichelmanE, RhodesB. Lactation patterns in women with hypertensive disorders of pregnancy: An analysis of Illinois 2012–2015 Pregnancy Risk Assessment Monitoring System (PRAMS) data. Matern Child Health J, 2021; 25(4):666–675.
BookhartLH, Devane-JohnsonS, Esquerra-ZwiersA, et al.Integrating biological, behavioral, and economic factors in the practice and study of early, unplanned lactation cessation. Breastfeed Med, 2025; 20(7):460–469; doi: 10.1089/bfm.2025.0071
50.
JohnsonTJ, Medina PoelinizC, MeierPP, et al.Pumping behaviors, pumped milk volume, and maternal opportunity cost for breast pump-dependent mothers of preterm infants in the first 14 postpartum days. Breastfeed Med, 2025; 20(7):502–511; doi: 10.1089/bfm.2025.0057
51.
PascualM, MigliorelliF, GobernaJ, et al.Impact of lactation consultants on the breastfeeding prevalence at 6 months: Systematic review and meta-analysis. Breastfeed Med, 2025; 20(12):871–887; doi: 10.1177/15568253251386459
52.
Medina PoelinizC, HobanR, JanesJ, et al.Pumping behaviors of breast pump-dependent mothers of preterm infants in the neonatal intensive care unit (NICU): Importance of the first five postpartum days. Breastfeed Med, 2025; 20(7):493–501; doi: 10.1089/bfm.2024.0396
53.
FokD, ArisIM, HoJ, et al.Early initiation and regular breast milk expression reduces risk of lactogenesis II delay in at-risk Singaporean mothers in a randomised trial. Singapore Med J, 2019; 60(2):80–88.
54.
Esquerra-ZwiersAL, MulderC, CzmerL, et al.Associations of secretory activation breast milk biomarkers with breastfeeding outcome measures. J Pediatr, 2023; 253:259–265.e2.
55.
JunterealN. Measuring human milk biomarkers at point-of-care. MCN Am J Matern Child Nurs, 2024; 49(2):116–117.
56.
HobanR, PatelAL, Medina PoelinizC, et al.Human milk biomarkers of secretory activation in breast pump-dependent mothers of preterm infants. Breastfeed Med, 2018; 13(5):352–360.
57.
FugateK, HernandezI, AshmeadeT, et al.Improving human milk and breastfeeding practices in the NICU. J Obstet Gynecol Neonatal Nurs, 2015; 44(3):426. E15.
58.
SpatzDL. Beyond BFHI: The Spatz 10-step and breastfeeding resource nurse model to improve human milk and breastfeeding outcomes. J Perinat Neonatal Nurs, 2018; 32(2):164–174.
59.
MartinJA, OstermanMJK. Increases in neonatal intensive care admissions in the United States, 2016-2023 (NCHS Data Brief No. 525). National Center for Health Statistics: Hyattsville, MD; 2025. Available from: https://www.cdc.gov/nchs/products/databriefs/db525.htm
60.
SpatzDL, FrohEB, SchwarzJ, et al.Pump early, pump often: A continuous quality improvement project. J Perinat Educ, 2015; 24(3):160–170.
61.
PengY, LiangY, JiangX, et al.Why emphasize early postpartum pumping? The critical window for coming to volume in pump-dependent mothers and its predictive value for feeding method at preterm infants’ discharge. Breastfeed Med, 2025; 20(12):895–903; doi: 10.1177/15568253251381804
62.
National Academies of Sciences, Engineering, and Medicine. Breastfeeding in the United States: Strategies to support families and achieve national goals. The National Academies Press: Washington, DC; 2025.
63.
SpatzDL. Benefits of mother–baby skin-to-skin contact. MCN Am J Matern Child Nurs, 2022; 47(3):170.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
